Growth Metrics

Inogen (INGN) Cash from Operations Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn 60.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.18%
Dec 31, 2025 68.75%
Sep 30, 2025 -69.01%
Jun 30, 2025 -34.97%
Mar 31, 2025 -253.55%
Dec 31, 2024 4.13%
Sep 30, 2024 220.00%
Jun 30, 2024 65.98%
Mar 31, 2024 24.63%
Dec 31, 2023 79.67%
Sep 30, 2023 123.04%
Jun 30, 2023 -27.14%
Mar 31, 2023 65.18%
Dec 31, 2022 -338.26%
Sep 30, 2022 -216.73%
Jun 30, 2022 -67.97%
Mar 31, 2022 -732.80%
Dec 31, 2021 -59.88%
Sep 30, 2021 -144.39%
Jun 30, 2021 27.63%
Mar 31, 2021 429.63%
Dec 31, 2020 72.52%
Sep 30, 2020 -53.80%
Jun 30, 2020 -26.58%
Mar 31, 2020 129.61%
Dec 31, 2019 -23.90%
Sep 30, 2019 1.56%
Jun 30, 2019 -12.35%
Mar 31, 2019 -114.90%
Dec 31, 2018 -5.16%
Sep 30, 2018 -17.25%
Jun 30, 2018 24.40%
Mar 31, 2018 -7.36%
Dec 31, 2017 151.02%
Sep 30, 2017 91.88%
Jun 30, 2017 40.59%
Mar 31, 2017 176.58%
Dec 31, 2016 -58.73%
Sep 30, 2016 -23.61%
Jun 30, 2016 56.31%
Mar 31, 2016 -21.18%
Dec 31, 2015 190.07%
Sep 30, 2015 269.48%
Jun 30, 2015 -18.97%
Mar 31, 2015 555.71%
Dec 31, 2014 117.65%
Sep 30, 2014 -30.28%
Jun 30, 2014 126.82%
Mar 31, 2014 -149.39%